The Zacks Analyst Blog Highlights: Johnson & Johnson, PayPal, Thermo Fisher, Celgene and American Airlines
For Immediate Release
Chicago, IL – February 02, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Johnson & Johnson ( NYSE:JNJ – Free Report ), PayPal ( NASDAQ:PYPL – Free Report ),Thermo Fisher ( NYSE:TMO – Free Report ), Celgene ( NASDAQ:CELG – Free Report ) and American Airlines ( NASDAQ:AAL – Free Report ).
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free .
Here are highlights from Wednesday’s Analyst Blog:
Top Research Reports for Thursday: JNJ, PYPL, TMO
Today's Research Daily features new research reports on 12 major stocks, including Johnson & Johnson ( NYSE:JNJ – Free Report ), PayPal ( NASDAQ:PYPL – Free Report ) and Thermo Fisher ( NYSE:TMO – Free Report ).
Johnson & Johnson have gained +8.5% over the last year, widely outperforming the large-cap pharma space (down -2.4%). J&J reported mixed fourth-quarter results, beating on earnings but missing on sales. However, the 2017 sales outlook was disappointing due to an expected slowdown in Pharma sales as a number of key growth drivers like Remicade and Concerta are facing competition.
While the company is faced with a number of headwinds like unfavorable currency movements, increased competition from generics, pricing pressures and an uncertain global macroeconomic backdrop, the analyst believes that JNJ's diversified business model, deep product pipeline, lack of cyclicality and financial strength position it for continued momentum going forward. (You can read the full research report on Johnson & Johnson here. )
PayPal shares have underperformed the Zacks Internet - Software industry over the last one year, gaining +7.3% vs +9%. However, the worldwide online payments system operator delivered decent fourth-quarter 2016 results, matching expectations on both counts. The analyst stresses that the company will continue to gain from partnerships and mobile centrism. PayPal’s ongoing strategic partnerships with Visa and MasterCard offer great flexibility and choice to consumers.
Partnerships with Facebook, Google, and Alibaba are also delivering positive results. Venmo continues to contribute significantly to the company’s mobile payment volume. However, continuous exposure to foreign exchange and interest rate risks is a concern. (You can read the full research report on PayPal here . )
Thermo Fisher have outperformed the broader medical sector (up more than 16.6% over the last one year vs -3.6% ), Thermo Fisher ended the year 2016 on a mixed note with adjusted earnings ahead of expectations and revenues lagging the same. However, the analyst likes the company’s recent product launches along with strong emerging markets growth.
Thermo Fisher’s acquisition of FEI Company is also going to significantly facilitate its performance in life-science research. The upcoming integration and expected synergy of Affimetrix is another positive. (You can read the full research report on Thermo Fisher here . )
Other noteworthy reports we are featuring today include Celgene ( NASDAQ:CELG – Free Report ) and American Airlines ( NASDAQ:AAL – Free Report ).
Zacks' Top 10 Stocks for 2017
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2017?
Who wouldn't? As of early December, the 2016 Top 10 produced 5 double-digit winners including oil and natural gas giant Pioneer Natural Resources which racked up a stellar +50% gain. The new list is painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. Be among the very first to see it>>
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free .
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.
Get the full Report on JNJ - FREE
Get the full Report on PYPL - FREE
Get the full Report on TMO - FREE
Get the full Report on CELG - FREE
Get the full Report on AAL - FREE
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com/
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.
This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Johnson & Johnson (JNJ): Free Stock Analysis Report
PayPal Holdings, Inc. (PYPL): Free Stock Analysis Report
Thermo Fisher Scientific Inc (TMO): Free Stock Analysis Report
Celgene Corporation (CELG): Free Stock Analysis Report
American Airlines Group, Inc. (AAL): Free Stock Analysis Report
To read this article on Zacks.com click here.
